The company is in discussions to resolve thousands of lawsuits. Participants in the talks value the plan at between $10 billion and $12 billion. The New York Times By JAN HOFFMAN from NYT Health https://ift.tt/30Fr9MV August 26, 2019 at 02:00PM
No comments:
Post a Comment